Meningococcal disease

N Engl J Med. 2001 May 3;344(18):1378-88. doi: 10.1056/NEJM200105033441807.

Authors

N E Rosenstein¹, B A Perkins, D S Stephens, T Popovic, J M Hughes

Affiliation

¹ Meningitis and Special Pathogens Branch, Division of Bacterial and Myocotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. nar5@cdc.gov

PMID: 11333996
DOI: 10.1056/NEJM200105033441807

No abstract available

Publication types

Review

MeSH terms

Anti-Bacterial Agents / therapeutic use
Antibiotic Prophylaxis
Cell Membrane
Disease Outbreaks
Global Health
Humans
Meningococcal Infections* / diagnosis
Meningococcal Infections* / drug therapy
Meningococcal Infections* / epidemiology
Meningococcal Infections* / prevention & control
Meningococcal Vaccines*
Neisseria meningitidis / classification
Neisseria meningitidis / ultrastructure
Risk Factors
Serotyping
United States / epidemiology
Vaccines, Conjugate

Substances

Anti-Bacterial Agents
Meningococcal Vaccines
Vaccines, Conjugate